Gilead Prices Its New STRIBILD Once a Day HIV Regimen Higher Than Complera and Atripla
Gilead has priced its STRIBILD at $28,500 / year. The other two single tablet HIV regimens, Complera and Atripla cost $26, 350 /year and $24,971.64/year, respectively. A regimen of twice a day raltegravir (Isentress) plus once a day Truvada costs $30,753 /year. Boosted Reyataz plus Truvada costs $34,390/year and boosted Prezista plus Truvada is …
Gilead Prices Its New STRIBILD Once a Day HIV Regimen Higher Than Complera and Atripla Read More »